City Therapeutics, Inc.
CTY- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002143850
In the last 90 days, City Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Key figures
- Market capNo recent share count in SEC filings
- –
- Insider buysLast 90 days, $3.06M in total
- 1
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 822.8K
- Shares sold short
- Change
- +822.8K
- +100.0% vs. previous
- Days to cover
- 2.27
- At average daily volume
Superinvestors holding CTY, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding CTY at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by City Therapeutics, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 19, 2026 (view filing)5:38 PM ET | Oct 19 | Same day | Crandell Keith and 5 others10% Owner | PPurchase | +170.0K | $18.00 | +$3.06M | +1.3%13.7M after | Duplicate filing |
| Oct 19, 2026 (view filing)5:37 PM ET | Oct 19 | Same day | Nelsen RobertDirector, 10% Owner | PPurchase | +170.0K | $18.00 | +$3.06M | +1.3%13.7M after |
Top 10 13F holders, Q2 2026
View all: Top 10 13F holders, Q2 2026The largest institutional positions in City Therapeutics, Inc. at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding CTY in 13F filings for Q2 2026.
Holders of 5% or more of CTY
See all 4 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of City Therapeutics, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| ARCH Venture Fund XII, L.P. | 13D | 25.60%13.7M shares | New | Oct 26, 20261 filing | Oct 26, 2026 | SEC |
| FMR LLC | 13G | 14.00%7.03M shares | New | Nov 6, 20261 filing | Nov 6, 2026 | SEC |
| Invus Global Management, LLC | 13G | 8.10%4.34M shares | New | Oct 22, 20261 filing | Oct 22, 2026 | SEC |
| Viking Global Investors LPSuperinvestorViking Global Investors | 13G | 7.00%3.73M shares | New | Oct 26, 20261 filing | Oct 26, 2026 | SEC |